[1] Lok AS,Mcmahon BJ,Jr BR,et al.Antiviral therapy for chronic hepatitis B viral infection in adults:A systematic review and Meta-analysis. Hepatology,2016,63(1):284-306. [2] 古雪,敬雪明,李铃,等. 慢性重型乙型肝炎患者医院感染特点及危险因素. 中国感染控制杂志,2016,15(7):518-520. [3] Lim YS,Byun KS,Yoo BC,et al.Tenofovir monotherapy versus tenofovir and entecavir combination therapy in patients with entecavir-resistant chronic hepatitis B with multiple drug failure: results of a randomised trial. Gut,2016,65(6):852-860. [4] Poynard T,Vergniol J,Ngo Y,et al.Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest) and transient elastography(FibroScan). J Hepatol,2014,60(4):706-714. [5] Enomoto M,Morikawa H,Tamori A,et al.Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B. World J Gastroenterol,2014,7(34):356-368. [6] Cassinotto C,Lapuyade B,Mouries A,et al.Non-invasive assessment of liver fibrosis with impulse elastography:comparison of supersonic shear imaging with ARFI and FibroScan. J Hepatol,2014,61(3):550-557. [7] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南(2015年版).实用肝脏病杂志,2016,19(3):Ⅴ-ⅩⅩⅢ. [8] Rammeh S,Khadra HB,Znaidi NS,et al.Inter-observes agreement of Ishak and Metavir scores in histological evaluation of chronic viral hepatitis B and C. Ann Biol Clin (Paris),2014,72(1):57-60. [9] Zhang X,Lu W,Zheng Y,et al.In situ analysis of intrahepatic virological events in chronic hepatitis B virus infection. J Clin Invest,2016,126(3):1079-1092. [10] Jonas MM,Lok AS,Mcmahon BJ,et al.Antiviral therapy in management of chronic hepatitis B viral infection in children:A systematic review and Meta-analysis. Hepatology,2016,63(1):307-318. [11] Papatheodoridis G,Vlachogiannakos I,Cholongitas E,et al.Discontinuation of oral antivirals in chronic hepatitis B:A systematic review. Hepatology,2016,63(5):1481-1492. [12] Ji Y,Wang LS,Shi H,et al.Sa1298 A comparison of histopathology of liver biopsy of chronic hepatitis B patients between Chinese-Americans in New York and Chinese in Shanghai. Gastroenterology,2014,146(5):S256. [13] Alboraie M,Khairy M,Elsharkawy A,et al.P0520:Acceptability,reliability and applicability of liver biopsy and non-invasive methods for assessment of hepatic fibrosis and cirrhosis among hepatologists;a web based survey. J Hepatol,2015,62(2):S510-S510. [14] Morisaka H,Motosugi U,Ichikawa S,et al.Magnetic resonance elastography is as accurate as liver biopsy for liver fibrosis staging. J Magn Reson Imaging,2017,47(1 Pt 1):24-28. [15] Kumar M,Rastogi A,Singh T,et al.Analysis of discordance between transient elastography and liver biopsy for assessing liver fibrosis in chronic hepatitis B virus infection. Hepatol Int,2013,7(1):134-143. [16] 丁荣蓉,陆伟,王雁冰,等. 采用FibroScan和天冬氨酸转氨酶与血小板比值指数评估慢性乙型肝炎患者肝纤维化程度. 中华传染病杂志,2017,35(8):467-471. [17] 杨硕,吕栋,王天懿,等. FibroTouch脂肪衰减参数对非酒精性脂肪性肝病患者肝脏脂肪变程度的诊断价值. 实用肝脏病杂志,2016,19(1):50-54. [18] Westin J,Lagging LM,Wejstål R,et al. Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection. Liver Int,2010,19(3):183-187. [19] 袁利超,邵金华,郝美娜,等. 肝脏硬度测定仪FibroTouch与FibroScan和肝脏病理分期的相关性. 中华肝脏病杂志,2014,22(6):425-429. [20] Calès P,Boursier J,Oberti F,et al.Cirrhosis diagnosis and liver fibrosis staging:Transient elastometry versus cirrhosis blood test. J Clin Gastroenterol,2015,49(6):512-519. |